Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced
Latest available record · 8 Oct 2026

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

Published by 10 Aug 2025
Drag the red line through time · ← → a day · Shift+← → a week. Later days aren’t drawn: they haven’t been published yet.
714not yet publishedAug 25Sep 25Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26

Scope · likely financings by canton

15 likely financings · 1 Aug 2025 – 10 Aug 2025 · the feed below shows one weekZH ✕ show all cantonsMap: Natural Earth

Likely financing
Looks like new money from outside investors: Claude, reading the entry and the rule signals, scores it 0.60 or higher.
Undecided
Some financing signals, not enough to call it: a score from 0.35 to below 0.60, or no usable score.
Capital increased
No sign of a financing round: the pre-filter found nothing to send to Claude, or Claude scored it below 0.35. Typical causes are converted loans, assets contributed in kind, reserves turned into capital or a conversion to an AG.
Confirmed round
A financing announcement on startupticker.ch names the company and matches this increase.

Published 4–10 Aug 2025 · canton ZH

15 capital increases · 6 shown
Showing: likely financings and confirmed rounds ▾
Show
Capital increases published 4–10 Aug 2025
CompanyStatusNominal share capital (CHF)
before → after		New shares, % of
post-step shares		Announced roundnot disclosed in the SHABSHAB publishedSource
nextesy AGZH · Zweck der Gesellschaft ist die Entwicklung, der Vertrieb sowie der Handel mit Software aller Art und …SHAB publication HR02-1006403937Likely financingscore 0.80235’133 → 267’833New shares 12.2%12.2%—8 Aug 2025SHAB publication HR02-1006403937
LimmaTech Biologics AGZH · Der Zweck der Gesellschaft ist die Forschung im Life-Sciences-Bereich sowie die Erbringung von damit im …SHAB publication HR02-1006403918Likely financingscore 0.88232’444.20 → 311’555.20New shares 25.4%25.4%—8 Aug 2025SHAB publication HR02-1006403918
Auxivo AGZH · Die Gesellschaft bezweckt die Entwicklung und die Herstellung von technischen Geräten, mechatronischen …SHAB publication HR02-1006402760Likely financingscore 0.72166’482 → 189’352.50New shares — nominal value per share changed— nominal value per share changed—7 Aug 2025SHAB publication HR02-1006402760
Mabylon AGZH · Die Gesellschaft bezweckt die Forschung im Bereich antikörperbasierter Pharmazeutika zur Behandlung und …SHAB publication HR02-1006401698Likely financingscore 0.703’390’517 → 8’390’517New shares 59.6%59.6%—6 Aug 2025SHAB publication HR02-1006401698
Calingo Insurance AGZH · Die Gesellschaft bezweckt die Entwicklung, die Vermittlung, das Underwriting, den Vertrieb und die Verwaltung …SHAB publication HR02-1006401638Likely financingscore 0.72222’584 → 244’150New shares 8.8%8.8%—6 Aug 2025SHAB publication HR02-1006401638
Simulands AGZH · Entwicklung, Erwerb von und Handel mit innovativen Produkten und Patenten sowie Finanzierung und Durchführung …SHAB publication HR02-1006400661Likely financingscore 0.68192’615.16 → 197’980.35New shares 2.7%2.7%—5 Aug 2025SHAB publication HR02-1006400661

9 other capital increases published this week ▸